Comparison Chart Noxopharm Limited

Equities

Delayed Australian S.E. Other stock markets 11:19:05 2024-05-16 pm EDT			5-day change	1st Jan Change
0.08 ^AUD	+2.56%		+26.98%	+12.68%

Apr. 04	Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug	MT
Feb. 27	Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	NOXOPHARM LIMITED	Biopharmaceuticals	+2.56%	+26.98%	+12.68%	+56.86%	-85.45%	15.23M